Otsuka Extends R&D MOU With Korea Until 2018
This article was originally published in PharmAsia News
Executive Summary
Otsuka is among six MNCs, including Pfizer, AstraZeneca, Novartis, Sanofi and Merck that have inked large R&D deals with Korea’s Ministry of Health.